A detailed history of Swiss National Bank transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Swiss National Bank holds 38,000 shares of FLGT stock, worth $640,300. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,000
Previous 41,200 7.77%
Holding current value
$640,300
Previous $808,000 2.1%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$19.6 - $25.06 $62,720 - $80,192
-3,200 Reduced 7.77%
38,000 $825,000
Q2 2024

Aug 08, 2024

BUY
$19.09 - $22.57 $53,452 - $63,196
2,800 Added 7.29%
41,200 $808,000
Q4 2023

Feb 06, 2024

SELL
$23.64 - $30.27 $96,924 - $124,107
-4,100 Reduced 9.65%
38,400 $1.11 Million
Q3 2023

Nov 08, 2023

SELL
$26.74 - $40.81 $74,872 - $114,268
-2,800 Reduced 6.18%
42,500 $1.14 Million
Q2 2023

Aug 09, 2023

BUY
$28.52 - $40.7 $114,080 - $162,800
4,000 Added 9.69%
45,300 $1.68 Million
Q1 2023

May 10, 2023

SELL
$29.39 - $36.27 $182,218 - $224,874
-6,200 Reduced 13.05%
41,300 $1.29 Million
Q4 2022

Feb 08, 2023

BUY
$29.23 - $40.28 $23,384 - $32,224
800 Added 1.71%
47,500 $1.41 Million
Q3 2022

Nov 09, 2022

BUY
$37.92 - $63.74 $30,336 - $50,992
800 Added 1.74%
46,700 $1.78 Million
Q1 2022

May 09, 2022

BUY
$49.85 - $96.11 $184,445 - $355,607
3,700 Added 8.77%
45,900 $2.87 Million
Q4 2021

Feb 08, 2022

BUY
$77.3 - $105.0 $46,380 - $63,000
600 Added 1.44%
42,200 $4.25 Million
Q3 2021

Nov 08, 2021

BUY
$74.87 - $110.87 $711,265 - $1.05 Million
9,500 Added 29.6%
41,600 $3.74 Million
Q2 2021

Aug 06, 2021

BUY
$66.8 - $100.45 $106,880 - $160,720
1,600 Added 5.25%
32,100 $2.96 Million
Q1 2021

May 07, 2021

BUY
$59.3 - $183.85 $189,760 - $588,320
3,200 Added 11.72%
30,500 $2.95 Million
Q4 2020

Feb 05, 2021

BUY
$31.01 - $52.1 $846,573 - $1.42 Million
27,300 New
27,300 $1.42 Million

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $510M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.